Evidence map›Paper›PMID 37681947›Full record

ArticlemSphere2023

Impact of corrosion inhibitors on antibiotic resistance, metal resistance, and microbial communities in drinking water.

Lee K Kimbell, Emily Lou LaMartina, Stan Kohls, Yin Wang, Ryan J Newton, Patrick J McNamara

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lee K KimbellDepartment of Civil, Construction and Environmental Engineering, Marquette University , Milwaukee, Wisconsin, USA.ORCID 0000-0003-1175-9453
Emily Lou LaMartinaSchool of Freshwater Sciences, University of Wisconsin-Milwaukee , Milwaukee, Wisconsin, USA.ORCID 0000-0001-5605-5949
Stan KohlsDepartment of Civil, Construction and Environmental Engineering, Marquette University , Milwaukee, Wisconsin, USA.
Yin WangDepartment of Civil and Environmental Engineering, University of Wisconsin-Milwaukee , Milwaukee, Wisconsin, USA.
Ryan J NewtonSchool of Freshwater Sciences, University of Wisconsin-Milwaukee , Milwaukee, Wisconsin, USA.ORCID 0000-0001-8946-0035
Patrick J McNamaraDepartment of Civil, Construction and Environmental Engineering, Marquette University , Milwaukee, Wisconsin, USA.ORCID 0000-0002-9708-3345
Marquette University · USUniversity of Wisconsin–Milwaukee · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corrosion inhibitors, including zinc orthophosphate, sodium orthophosphate, and sodium silicate, are commonly used to prevent the corrosion of drinking water infrastructure. Metals such as zinc are known stressors for antibiotic resistance selection, and phosphates can increase microbial growth in drinking water distribution systems (DWDS). Yet, the influence of corrosion inhibitor type on antimicrobial resistance in DWDS is unknown. Here, we show that sodium silicates can decrease antibiotic resistant bacteria (ARB) and antibiotic-resistance genes (ARGs), while zinc orthophosphate increases ARB and ARGs in source water microbial communities. Based on controlled bench-scale studies, zinc orthophosphate addition significantly increased the abundance of ARB resistant to ciprofloxacin, sulfonamides, trimethoprim, and vancomycin, as well as the genes

Indexed as

Drinking WaterMicrobiotaAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsAnti-Bacterial AgentsCorrosionDrug Resistance, MicrobialHumansPhosphatesSilicatesSodiumZincAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsAnti-Bacterial AgentsDrinking WaterPhosphatesSilicatesSodiumsodium silicateZincantimicrobial resistancemetalspollution controlsodium orthophosphatezinc

Identifiers

PMID37681947
PMCPMC10597465
OpenAlexW4386529729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.